Gilead Sciences (GILD) Price to Earnings (2009 - 2026)

Gilead Sciences (GILD) has reported Price to Earnings for 18 consecutive years, with 14.94 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings fell 121.27% year-over-year to 14.94; the trailing twelve-month figure through Jun 2026 stood at 54.16 (down 348.21% YoY), and the FY2025 full-year result was 17.9, down 92.55% from the prior year.
• Price to Earnings eased to 14.94 in Q2 2026 per GILD's latest filing, from 85.65 in the prior quarter.
• Across five years, Price to Earnings topped out at 6217.48 in Q1 2022 and bottomed at 21.88 in Q1 2024.
• Historically, Price to Earnings has averaged 402.12 across 5 years, with a median of 66.92 in 2022.
• The sharpest annual moves came in 2022 and 2026: Price to Earnings soared 13110.4% in 2022, then plunged 121.27% in 2026.
• Over 5 years, Price to Earnings stood at 65.56 in 2022, then increased by 8.74% to 71.28 in 2023, then fell by 9.4% to 64.59 in 2024, then dropped by 6.71% to 60.25 in 2025, then tumbled by 124.79% to 14.94 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 14.94, 85.65, and 60.25 for Q2 2026, Q1 2026, and Q4 2025 respectively.